The future is open to all
At CLP, we do not only see opportunities, we help to create them too. We have extensive experience in the areas of Private Equity and Venture Capital, and advise leading Norwegian and foreign investment companies, entrepreneurial environments and funds, and investors and facilitators.
We have specialist expertise in the regulatory framework and investment terms used in the sector. We are one of the foremost law firms when it comes to establishing Private Equity and Venture Capital funds.
CLP with top rankings in the yearly election of lawyers in Norway
Finansavisen/Kapital has presented the yearly ranking of lawyers in Norway today, and CLP is happy to receive the follow...
CLP is advising General Atlantic in offer for Adevinta
CLP has had the pleasure of advising leading global Private Equity firm General Atlantic in connection with the recently...
CLP assisted Nysnø in its cornerstone investment in Alliance Venture Delta
Alliance Venture recently launched its new venture fund Alliance Venture Delta AB, targeting early- stage founders and s...
CLP has assisted Fusetools AS
CLP has assisted Fusetools AS in executing a private placement raising approx. NOK 100 million in new equity. Fusetools...
Q-Free raises NOK 133.8 million in Private Placement
CLP has assisted Q-Free ASA in executing a Private Placement raising a total of NOK 133.8 million in new equity and with...
Norfund, Rabobank and FMO join forces
CLP has assisted Norfund in the establishment of a joint venture together with FMO and Rabobank for investment in financ...
poLight raises NOK 160 million in Pre-IPO funding round
A team of CLP lawyers, lead by Jakob Villum, have assisted poLight in executing a Private Placement raising a total of N...
Ferd/Mestergruppen offer to purchase all shares in Nordek
CLP has assisted Mestergruppen and Ferd with Mestergruppen's offer to purchase all shares in Nordek, a company owning th...
CLP has assisted Bionor Pharma
CLP has assisted Bionor Pharma in its NOK 1 billion acquisition of Solon Eiendom AS, and will assist Bionor Pharma in a...